MIR21 and breast carcinoma: On the other hand, further studies are still needed to explore the role of VMP1/MIR21 in the mechanism for the paclitaxel resistance of TNBCs as miR‐21 has been shown to be a useful biomarker to predict neoadjuvant therapeutic response in breast cancer patients.32